RCUS FY 2022 Earnings — Arcus Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RCUSArcus Biosciences, Inc.

$2B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$112M-70.8% YoY

Gross Profit

$112M100.0% margin

Operating Income

-$280M-250.0% margin

Net Income

-$267M-238.4% margin

EPS (Diluted)

$-3.71

Cash Flow

Operating Cash Flow

$438M

Free Cash Flow

$432M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$688M

Stockholders' Equity

$657M

Cash & Equivalents

$206M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$112M	$383M	-70.8%
Gross Profit	$112M	$383M	-70.8%
Operating Income	-$280M	$54M	-618.5%
Net Income	-$267M	$53M	-603.8%